CTC
FOLD

Cetera Trust Company’s Amicus Therapeutics FOLD Stock Holding History

Cetera Trust Company’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-251
Closed -$2.68K – 393
2024
Q3 		$2.68K Hold
251
– – ﹤0.01% 395
2024
Q2 		$2.49K Hold
251
– – ﹤0.01% 402
2024
Q1 		$2.96K Hold
251
– – ﹤0.01% 405
2023
Q4 		$3.56K Buy
+251
New +$2.85K ﹤0.01% 399

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cetera Trust Company's FOLD Position: Q4 2024 in Review

Cetera Trust Company sold out of Amicus Therapeutics (FOLD) in Q4 2024, closing a stake of 251 shares — an estimated $2.68K sold.

Cetera Trust Company first reported a position in FOLD in Q4 2023 and held it in 4 quarters. The position peaked at $3.56K in Q4 2023. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.

  • Cetera Trust Company reported no remaining Amicus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cetera Trust Company sold 251 Amicus Therapeutics shares in Q4 2024, an estimated $2.68K.
  • Cetera Trust Company first reported a position in Amicus Therapeutics in Q4 2023 and held it in 4 quarters.
  • Cetera Trust Company's Amicus Therapeutics position peaked at $3.56K in Q4 2023.
  • 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.

Based on Cetera Trust Company's 13F filing for Q4 2024, filed 17 Jan 2025.